Form 8-K - Current report:
SEC Accession No. 0001493152-24-036852
Filing Date
2024-09-17
Accepted
2024-09-17 16:05:26
Documents
13
Period of Report
2024-09-17
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38151
  Complete submission text file 0001493152-24-036852.txt   213562

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vvos-20240917.xsd EX-101.SCH 3006
3 XBRL LABEL FILE vvos-20240917_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE vvos-20240917_pre.xml EX-101.PRE 24159
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3694
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 241304256
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)